Medical professionals and industry leaders agree: we need to conduct more research on cannabis.Medical professionals and industry leaders agree: we need to conduct more research on cannabis.
The Schedule I status of marijuana stunts America’s ability to contribute to worldwide cannabis research. In light of the recent COVID-19 pandemic, these limitations became that much more apparent.